Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / JAZZ - Jazz Pharmaceuticals: A New Drug New Acquisition But Possibly Overpriced

JAZZ - Jazz Pharmaceuticals: A New Drug New Acquisition But Possibly Overpriced

Jazz Pharmaceuticals plc
  • Jazz has announced the launch of its latest drug, Xywav: the first and only treatment option for idiopathic hypersomnia, with the potential for further indications in future.
  • It has recently completed the acquisition of GW Pharmaceuticals and its portfolio of cannabis derived drugs, some of which have blockbuster potential.
  • Jazz holds a significant amount of debt and is facing several lawsuits that could lead to fines and further generic competition.

For further details see:

Jazz Pharmaceuticals: A New Drug, New Acquisition, But Possibly Overpriced
Stock Information
Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com
Menu
JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...